Over two decades in the CRO/CDMO arena, I shaped and executed programs spanning discovery, preclinical, CMC development, GMP manufacturing, and early-phase clinical research across US, European, and Asia-Pacific biotech and pharma companies. I encompassed building business development teams, managing integrated drug development value chains, and bridging operational and regulatory divides between Western sponsors and Indian service providers. During this tenure, I witnessed too many programs derailed by misalignment, weak partner governance or documentation gaps; therefore, I found Aventiq Bio with one clear mission: to deliver outsourcing to India with 100% conviction, zero surprises, and uncompromised regulatory/quality standards. I now lead Aventiq Bio in raising the benchmark — by choosing the right partner, managing the program end-to-end, and ensuring your IND/CMC success from day one. I guarantee that when you engage Aventiq Bio, you are backed by someone who’s walked both sides of the table — as a sponsor and a service provider — and demands the same discipline you expect in the US/Europe.